$Cerulean Pharma(CERU)$ 8-K - Current report Filed: 2016-11-03 AccNo: 0001564590-16-027382 Size: 129 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cerulean Pharma(CERU)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-03 AccNo: 0001564590-16-027350 Size: 4 MB 网页链接
$Cerulean Pharma(CERU)$ 美东时间 2016-11-03 16:30 After Market Close:CERULEAN PHARMA Earning Release . Wall St EPS Est ($):-0.42. 网页链接
$Cerulean Pharma(CERU)$ 8-K - Current report Filed: 2016-10-19 AccNo: 0001193125-16-741275 Size: 45 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Cerulean Pharma(CERU)$ 8-K - Current report Filed: 2016-10-18 AccNo: 0001193125-16-740876 Size: 255 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Cerulean Pharma(CERU)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2016-10-18 AccNo: 0001193125-16-740863 Size: 320 KB 网页链接
$Cerulean Pharma(CERU)$ EFFECT - Notice of Effectiveness Filed: 2016-10-14 AccNo: 9999999995-16-005972 Size: 1 KB 网页链接
$Cerulean Pharma(CERU)$ D - Notice of Exempt Offering of Securities Filed: 2016-10-17 AccNo: 0001401914-16-000005 Size: 14 KB 网页链接
$Cerulean Pharma(CERU)$ POS AM - Post-Effective amendments for registration statement Filed: 2016-10-13 AccNo: 0001193125-16-737631 Size: 310 KB 网页链接
$Cerulean Pharma(CERU)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-09-12 AccNo: 0000315066-16-006189 Size: 8 KB 网页链接